4
Changes in Ownership
VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-26-000004
EVP, Chief Reg. & Quality Off. sold 4,500 shares at $474.99 ($2,137,455)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Tatsis Ourania · EVP, Chief Reg. & Quality Off.
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-01-07 | Sale : show line 1 in the form 10b5-1 | −4,500 | $474.99 | $2,137,455 | 42,293 | D |
| Open-market sales · 4,500 sh · avg $474.99 · $2,137,455 | ||||||
Loading xslF345X05/wk-form4_1767992722.xml…